Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA
Go back to Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA| (NASDAQ: PHAT) | Delayed: 8.62 -0.7 (7.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.32 | 52 Week High | $ | |||
| Open | $9.25 | 52 Week Low | $ | |||
| Day High | $9.30 | P/E | N/A | |||
| Day Low | $8.61 | EPS | $ | |||
| Volume | 372,294 | |||||

